Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation

Todd D. Reil, Vikram S. Kashyap, Rajabrata Sarkar, Julie Freishlag, Hugh A. Gelabert

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We have previously demonstrated that dexamethasone (DEX) suppresses neointimal hyperplasia and proliferation of rat aortic smooth muscle cells (SMC) by inducing a late G1 phase cell cycle arrest. Phosphorylation of retinoblastoma protein (Rb) regulates cell proliferation by controlling progression from G1 to S phase of the cell cycle. We hypothesized that DEX inhibits human vascular SMC proliferation and causes cell cycle arrest through inhibition of Rb phosphorylation. Human aortic SMC were cultured and treated with incremental doses of DEX. Cell counts and [3H]thymidine uptake were determined after 72 h. To examine the effects of DEX on the cell cycle, cells were synchronized by serum deprivation, restimulated to enter G1 phase, and treated with 10-5) M DEX, and protein was extracted at sequential time points. Flow cytometry was performed to track cell cycle progression. Western blots were performed to examine Rb phosphorylation. DEX inhibited smooth muscle cell proliferation and DNA synthesis in a concentration-dependent fashion. Flow cytometry indicated that DEX induces a G1 phase cell cycle arrest. DEX inhibited the phosphorylation of Rb protein compared to control. DEX inhibits the proliferation of human vascular SMC by inducing G1 phase cell cycle arrest. DEX inhibited the phosphorylation of Rb, a key step in the progression of the cell from G1 to S phase. Elucidation of the mechanism of DEX may be helpful in treatment strategies for preventing neointimal hyperplasia as well as other disorders of cell proliferation. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)108-113
Number of pages6
JournalJournal of Surgical Research
Volume92
Issue number1
DOIs
StatePublished - Jul 2000

Fingerprint

Retinoblastoma Protein
Vascular Smooth Muscle
Dexamethasone
Smooth Muscle Myocytes
Phosphorylation
Cell Proliferation
G1 Phase
G1 Phase Cell Cycle Checkpoints
Cell Cycle
S Phase
Hyperplasia
Flow Cytometry
Cell Cycle Checkpoints
Thymidine
Cell Count
Western Blotting

Keywords

  • Cell cycle
  • Cell proliferation
  • Dexamethasone
  • Human vascular smooth muscle cells
  • Neointimal hyperplasia
  • Retinoblastoma protein

ASJC Scopus subject areas

  • Surgery

Cite this

Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation. / Reil, Todd D.; Kashyap, Vikram S.; Sarkar, Rajabrata; Freishlag, Julie; Gelabert, Hugh A.

In: Journal of Surgical Research, Vol. 92, No. 1, 07.2000, p. 108-113.

Research output: Contribution to journalArticle

Reil, Todd D. ; Kashyap, Vikram S. ; Sarkar, Rajabrata ; Freishlag, Julie ; Gelabert, Hugh A. / Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation. In: Journal of Surgical Research. 2000 ; Vol. 92, No. 1. pp. 108-113.
@article{082b7429bcc0469ab8c903a902ab0b0c,
title = "Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation",
abstract = "We have previously demonstrated that dexamethasone (DEX) suppresses neointimal hyperplasia and proliferation of rat aortic smooth muscle cells (SMC) by inducing a late G1 phase cell cycle arrest. Phosphorylation of retinoblastoma protein (Rb) regulates cell proliferation by controlling progression from G1 to S phase of the cell cycle. We hypothesized that DEX inhibits human vascular SMC proliferation and causes cell cycle arrest through inhibition of Rb phosphorylation. Human aortic SMC were cultured and treated with incremental doses of DEX. Cell counts and [3H]thymidine uptake were determined after 72 h. To examine the effects of DEX on the cell cycle, cells were synchronized by serum deprivation, restimulated to enter G1 phase, and treated with 10-5) M DEX, and protein was extracted at sequential time points. Flow cytometry was performed to track cell cycle progression. Western blots were performed to examine Rb phosphorylation. DEX inhibited smooth muscle cell proliferation and DNA synthesis in a concentration-dependent fashion. Flow cytometry indicated that DEX induces a G1 phase cell cycle arrest. DEX inhibited the phosphorylation of Rb protein compared to control. DEX inhibits the proliferation of human vascular SMC by inducing G1 phase cell cycle arrest. DEX inhibited the phosphorylation of Rb, a key step in the progression of the cell from G1 to S phase. Elucidation of the mechanism of DEX may be helpful in treatment strategies for preventing neointimal hyperplasia as well as other disorders of cell proliferation. (C) 2000 Academic Press.",
keywords = "Cell cycle, Cell proliferation, Dexamethasone, Human vascular smooth muscle cells, Neointimal hyperplasia, Retinoblastoma protein",
author = "Reil, {Todd D.} and Kashyap, {Vikram S.} and Rajabrata Sarkar and Julie Freishlag and Gelabert, {Hugh A.}",
year = "2000",
month = "7",
doi = "10.1006/jsre.2000.5942",
language = "English (US)",
volume = "92",
pages = "108--113",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation

AU - Reil, Todd D.

AU - Kashyap, Vikram S.

AU - Sarkar, Rajabrata

AU - Freishlag, Julie

AU - Gelabert, Hugh A.

PY - 2000/7

Y1 - 2000/7

N2 - We have previously demonstrated that dexamethasone (DEX) suppresses neointimal hyperplasia and proliferation of rat aortic smooth muscle cells (SMC) by inducing a late G1 phase cell cycle arrest. Phosphorylation of retinoblastoma protein (Rb) regulates cell proliferation by controlling progression from G1 to S phase of the cell cycle. We hypothesized that DEX inhibits human vascular SMC proliferation and causes cell cycle arrest through inhibition of Rb phosphorylation. Human aortic SMC were cultured and treated with incremental doses of DEX. Cell counts and [3H]thymidine uptake were determined after 72 h. To examine the effects of DEX on the cell cycle, cells were synchronized by serum deprivation, restimulated to enter G1 phase, and treated with 10-5) M DEX, and protein was extracted at sequential time points. Flow cytometry was performed to track cell cycle progression. Western blots were performed to examine Rb phosphorylation. DEX inhibited smooth muscle cell proliferation and DNA synthesis in a concentration-dependent fashion. Flow cytometry indicated that DEX induces a G1 phase cell cycle arrest. DEX inhibited the phosphorylation of Rb protein compared to control. DEX inhibits the proliferation of human vascular SMC by inducing G1 phase cell cycle arrest. DEX inhibited the phosphorylation of Rb, a key step in the progression of the cell from G1 to S phase. Elucidation of the mechanism of DEX may be helpful in treatment strategies for preventing neointimal hyperplasia as well as other disorders of cell proliferation. (C) 2000 Academic Press.

AB - We have previously demonstrated that dexamethasone (DEX) suppresses neointimal hyperplasia and proliferation of rat aortic smooth muscle cells (SMC) by inducing a late G1 phase cell cycle arrest. Phosphorylation of retinoblastoma protein (Rb) regulates cell proliferation by controlling progression from G1 to S phase of the cell cycle. We hypothesized that DEX inhibits human vascular SMC proliferation and causes cell cycle arrest through inhibition of Rb phosphorylation. Human aortic SMC were cultured and treated with incremental doses of DEX. Cell counts and [3H]thymidine uptake were determined after 72 h. To examine the effects of DEX on the cell cycle, cells were synchronized by serum deprivation, restimulated to enter G1 phase, and treated with 10-5) M DEX, and protein was extracted at sequential time points. Flow cytometry was performed to track cell cycle progression. Western blots were performed to examine Rb phosphorylation. DEX inhibited smooth muscle cell proliferation and DNA synthesis in a concentration-dependent fashion. Flow cytometry indicated that DEX induces a G1 phase cell cycle arrest. DEX inhibited the phosphorylation of Rb protein compared to control. DEX inhibits the proliferation of human vascular SMC by inducing G1 phase cell cycle arrest. DEX inhibited the phosphorylation of Rb, a key step in the progression of the cell from G1 to S phase. Elucidation of the mechanism of DEX may be helpful in treatment strategies for preventing neointimal hyperplasia as well as other disorders of cell proliferation. (C) 2000 Academic Press.

KW - Cell cycle

KW - Cell proliferation

KW - Dexamethasone

KW - Human vascular smooth muscle cells

KW - Neointimal hyperplasia

KW - Retinoblastoma protein

UR - http://www.scopus.com/inward/record.url?scp=0034235194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034235194&partnerID=8YFLogxK

U2 - 10.1006/jsre.2000.5942

DO - 10.1006/jsre.2000.5942

M3 - Article

C2 - 10864490

AN - SCOPUS:0034235194

VL - 92

SP - 108

EP - 113

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -